Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. BKYI
BKYI logo

BKYI Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
2.81M
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
3.12M
EV/OCF(TTM)
--
P/S(TTM)
0.28
BIO-key International, Inc. is a provider of workforce and customer identity and access management (IAM) solutions featuring passwordless, phoneless and token-less Identity-Bound Biometric (IBB) authentication. The Company’s IAM platform enables secure work-from-anywhere for enterprise, education, and government customers using secure multi-factor authentication (MFA). Its products include PortalGuard and PortalGuard Identity-as-a-Service (IDaaS) enterprise IAM, WEB-key biometric civil and large-scale ID infrastructure, MobileAuth mobile phone authentication application for iOS and Android, and quality accessory fingerprint scanner and FIDO-compliant hardware to provide complete solution for identity-innovating customers. Its PortalGuard is a cloud-based identity platform that allows its customers to integrate with any cloud or on-premise SaaS application, service or cloud host, as well as Windows device authentication through a single IAM platform.
Show More

Events Timeline

(ET)
2026-05-12
17:00:00
BIO-key International Stock to Be Suspended on Nasdaq
select
2026-05-12
13:10:00
Biokey International Trading Halted
select
2026-04-29 (ET)
2026-04-29
20:00:00
Biokey International Trading Halted, News Pending
select
2026-04-16 (ET)
2026-04-16
08:10:00
Q1'26 Revenues Expected to Grow 37% to $2.2M
select
2026-04-16
08:10:00
BIO-key CEO Expects Solid Performance Improvements in H1 2026
select
2026-04-16
08:10:00
Q2'26 Revenues Expected to Grow 65% to $2.8M
select
2026-03-12 (ET)
2026-03-12
08:10:00
BIO-key Forms Strategic Partnership with TD SYNNEX Public Sector
select
2026-03-05 (ET)
2026-03-05
05:10:00
BIO-key Secures $280,000 New Order for Biometric Authentication
select

News

Yahoo Finance
9.5
05-18Yahoo Finance
BIO-key International Reports 34% Revenue Growth in Q1 2026
  • Significant Revenue Growth: BIO-key International reported a 34% increase in Q1 2026 revenues to $2.1 million, driven by new customer acquisitions and expanded deployments, laying a solid foundation for future market expansion.
  • Strong Gross Margin: The company maintained a gross margin of 82% in Q1 2026, consistent with 2025, highlighting the advantages of high-margin license fee revenue and sales of fully reserved inventory, which bolster profitability.
  • Improved Net Loss: Although the net loss for Q1 2026 was $165,036, an improvement from $736,545 in Q1 2025, ongoing privacy and regulatory challenges in the U.S. market could impact future financial performance.
  • Optimistic Market Outlook: BIO-key's partnership with DLT Solutions provides a streamlined procurement path for public sector customers, which is expected to enhance market penetration in defense and financial services, strengthening its long-term growth potential.
seekingalpha
9.5
05-18seekingalpha
BIO-key International Q1 2026 Earnings Call Insights
  • Significant Revenue Growth: BIO-key International reported a 34% year-over-year revenue increase in Q1 2026, reaching $2.1 million compared to $1.6 million in Q1 2025, indicating strong performance from new customer acquisitions and long-term deployments in defense and financial services.
  • Hardware Revenue Doubling: The company's hardware revenue surged over 100% to approximately $531,000, reflecting a significant increase in hardware demand as larger licensing opportunities close, thereby enhancing profit margins.
  • NASDAQ Return Plan: The company is actively pursuing its NASDAQ appeal process, with a hearing scheduled for June 16, and management expresses optimism about returning to NASDAQ trading by summer, which could boost investor confidence and market recognition.
  • Positive Future Outlook: Management anticipates profitability and positive cash flow in Q2, emphasizing that as revenue scales up, profits will significantly increase, indicating the company's growth potential and competitive positioning in the market.
seekingalpha
9.5
05-18seekingalpha
BIO-key Q1 Earnings Report Analysis
  • Earnings Performance: BIO-key reported a Q1 GAAP EPS of -$0.15 with revenues of $2.15 million, reflecting a 34% year-over-year increase, yet it missed expectations by $0.05 million, indicating challenges in revenue growth.
  • Future Outlook: The company anticipates a 65% revenue increase in Q2 2025 to approximately $2.8 million compared to $1.7 million in Q2 2025, showcasing confidence in future growth while needing to overcome current financial pressures.
  • Profitability Expectations: BIO-key expects to achieve profitability in H1 2026 with projected revenues of $5 million, a significant turnaround from a net loss of $1.9 million in H1 2025, indicating efforts to improve financial health.
  • Cash Position: The cash position for H1 2026 is expected to remain in line with the current status, and despite challenges, the company maintains an optimistic outlook for revenue growth and improved bottom line for the full year 2026.
seekingalpha
7.0
04-22seekingalpha
BIO-key International Receives Nasdaq Notice for Filing Delay
  • Nasdaq Notice: BIO-key International received a notice from Nasdaq for failing to comply with listing requirements due to a delay in filing its fiscal 2025 annual report, which pertains to Listing Rule 5250(c)(1) requiring timely submission of financial reports to the SEC.
  • Impact Assessment: Despite the notice, BIO-key stated that it has no immediate impact on the listing or trading of its shares, indicating the company's stability in compliance matters.
  • Audit Progress: The company is working with auditors and expects to submit the Form 10-K next week, demonstrating its proactive approach and plans to resolve compliance issues.
  • Future Outlook: BIO-key anticipates approximately $2.2 million in revenue for Q1 2026, targeting breakeven and profitability in 2026, reflecting the company's confidence in its future financial health.
Yahoo Finance
9.5
03-31Yahoo Finance
BIO-key International Inc Reports Mixed 2025 Financial Results
  • Revenue Growth Expectations: BIO-key International Inc anticipates Q1 2026 revenue of approximately $2.2 million, reflecting a 37% increase over Q1 2025, indicating potential recovery in the market despite a 12% decline in total revenue to $6.1 million in 2025.
  • Hardware and Service Revenue Increase: In 2025, hardware revenue surged over 100% to $1.3 million, while service revenue rose 6% to $1.2 million, demonstrating ongoing growth in product sales and services, even as overall gross margin decreased to 77.5%.
  • Improved Cash Flow and Asset Position: By the end of 2025, the company reported cash reserves of $2.7 million, up more than $2 million from 2024, enhancing financial stability, while book value increased from $3.8 million to $7.6 million, reflecting healthy asset growth.
  • Increased Net Loss: The net loss for 2025 rose to $4.6 million, or $0.69 per share, compared to $4.3 million and $2.09 per share in 2024, highlighting challenges faced during the transition, particularly in the slower-than-expected brand shift in the EMEA region.
seekingalpha
9.5
03-31seekingalpha
BIO-key International Q4 2025 Earnings Call Insights
  • Revenue Expectations Rise: BIO-key anticipates Q1 2026 revenue of approximately $2.2 million, representing a 37% increase over Q1 2025, indicating significant progress in revenue recovery that is expected to enhance overall financial performance.
  • Strategic Transition Completed: The company completed its strategic shift to selling only BIO-key branded solutions in 2025, which is expected to improve gross margins and enhance growth prospects, particularly in the competitive EMEA market.
  • Cost Control Effectiveness: In 2025, BIO-key successfully reduced SG&A expenses by nearly $800,000, an 11% decrease, while cash reserves reached $2.7 million, demonstrating ongoing improvements in operational efficiency.
  • Product Release Progress: BIO-key formally introduced the FBI FAP 20 certified EcoID III fingerprint scanner and expects PortalGuard 7.0 to be released in Q2 2026, which will further strengthen its market position in regulated industries.

Valuation Metrics

The current forward P/E ratio for BIO-Key International Inc (BKYI.O) is 0.00, compared to its 5-year average forward P/E of -8.70. For a more detailed relative valuation and DCF analysis to assess BIO-Key International Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-8.70
Current PE
0.00
Overvalued PE
7.06
Undervalued PE
-24.46

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
-0.09
Current EV/EBITDA
-0.07
Overvalued EV/EBITDA
0.30
Undervalued EV/EBITDA
-0.49

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
0.94
Current PS
0.31
Overvalued PS
1.64
Undervalued PS
0.23

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

positive macd and expanding
Intellectia · 1739 candidates
Region: USList Exchange: XNYS, XNAS, XASEMacd: positive, bullish
Ticker
Name
Market Cap$
top bottom
WTO logo
WTO
UTime Ltd
1.13M
PZG logo
PZG
Paramount Gold Nevada Corp
163.38M
DVA logo
DVA
DaVita Inc
9.26B
GORO logo
GORO
Gold Resource Corp
250.87M
CDT logo
CDT
CDT Equity Inc
2.68M
DSS logo
DSS
DSS Inc
11.68M
information technology
Intellectia · 58 candidates
Sector: Financial Technology (Fintech) & Infrastructure, Software & IT Services, Technology, Technology Equipment, Telecommunications ServicesRegion: USRsi Category: moderate, oversoldList Exchange: XNYS, XNAS, XASEMoving Average Relationship: PriceAboveMA5One Day Predict Return: >= 0.5%Monthly Average Dollar Volume: >= 300,000
Ticker
Name
Market Cap$
top bottom
JBL logo
JBL
Jabil Inc
25.64B
BKYI logo
BKYI
BIO-Key International Inc
7.20M
DV logo
DV
DoubleVerify Holdings Inc
1.76B
TME logo
TME
Tencent Music Entertainment Group
26.28B
SSTK logo
SSTK
Shutterstock Inc
699.75M
TU logo
TU
Telus Corp
21.62B
how about only stocks under $20
Intellectia · 22 candidates
Sector: Financial Technology (Fintech) & Infrastructure, Software & IT Services, Technology, Technology EquipmentRegion: USPrice: <= $20.00Rsi Category: moderateList Exchange: XNASMoving Average Relationship: PriceAboveMA20, PriceAboveMA200Month Price Change Pct: $5.00 - $30.00One Week Rise Prob: >= 0One Week Predict Return: >= 0.0%Monthly Average Dollar Volume: >= 1,000,000
Ticker
Name
Market Cap$
top bottom
TLS logo
TLS
Telos Corp
423.03M
SIFY logo
SIFY
Sify Technologies Ltd
1.03B
SSYS logo
SSYS
Stratasys Ltd
960.30M
LTRX logo
LTRX
Lantronix Inc
261.73M
BKYI logo
BKYI
BIO-Key International Inc
8.78M
CRNC logo
CRNC
Cerence Inc
551.90M

Whales Holding BKYI

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is BIO-Key International Inc (BKYI) stock price today?

The current price of BKYI is 0 USD — it has decreased -53.47

What is BIO-Key International Inc (BKYI)'s business?

BIO-key International, Inc. is a provider of workforce and customer identity and access management (IAM) solutions featuring passwordless, phoneless and token-less Identity-Bound Biometric (IBB) authentication. The Company’s IAM platform enables secure work-from-anywhere for enterprise, education, and government customers using secure multi-factor authentication (MFA). Its products include PortalGuard and PortalGuard Identity-as-a-Service (IDaaS) enterprise IAM, WEB-key biometric civil and large-scale ID infrastructure, MobileAuth mobile phone authentication application for iOS and Android, and quality accessory fingerprint scanner and FIDO-compliant hardware to provide complete solution for identity-innovating customers. Its PortalGuard is a cloud-based identity platform that allows its customers to integrate with any cloud or on-premise SaaS application, service or cloud host, as well as Windows device authentication through a single IAM platform.

What is the price predicton of BKYI Stock?

Wall Street analysts forecast BKYI stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for BKYI is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is BIO-Key International Inc (BKYI)'s revenue for the last quarter?

BIO-Key International Inc revenue for the last quarter amounts to 2.15M USD, increased 33.50

What is BIO-Key International Inc (BKYI)'s earnings per share (EPS) for the last quarter?

BIO-Key International Inc. EPS for the last quarter amounts to -0.15 USD, decreased -90.45

How many employees does BIO-Key International Inc (BKYI). have?

BIO-Key International Inc (BKYI) has 41 emplpoyees as of May 31 2026.

What is BIO-Key International Inc (BKYI) market cap?

Today BKYI has the market capitalization of 2.81M USD.